ArticleAnnals of intensive care2022

Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study.

Romain Arrestier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.